This 1999 study examined the effects of zinc on the growth of human prostate cancer cell lines LNCaP (androgen-sensitive) and PC-3 (androgen-independent). Exposure to physiological concentrations of zinc (100–1,000 ng/ml) resulted in significant growth inhibition in both cell lines, with LNCaP cells exhibiting greater sensitivity (IC50 ~100 ng/ml) compared to
